Updated Information Regarding Tirzepatide 

Update on Mounjaro

From April 2026, GP practices can prescribe Tirzepatide (Mounjaro®) for weight management for patients who meet NHS England and NICE eligibility criteria.
 

Eligible patients

You must meet both of the following criteria:
1. Body Mass Index (BMI)
  • BMI of 35 kg/m² or above, or
  • BMI of 32.5 kg/m² or above if you are from a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background.
2. At least four of the following conditions:
  • Established cardiovascular disease
  • High blood pressure requiring medication
  • High cholesterol or cholesterol-lowering treatment
  • Obstructive sleep apnoea requiring CPAP (confirmed by a sleep clinic)
  • Type 2 diabetes

When can't the GP prescribe Mounjaro?

GPs cannot prescribe Tirzepatide for weight management unless the NHS eligibility criteria are met. This includes requests for mild or moderate obesity, private requests, or use without qualifying medical conditions.
 

Behavioural support programme 

Participation in the NHS Behavioural Support for Obesity Prescribing Programme is mandatory for all patients prescribed tirzepatide. Locally, this is delivered by Xyla over 9 months.
 

Other support options 

If Tirzepatide is not suitable for you, we can discuss alternative options, including dietary advice, lifestyle support, physical activity programmes, and referral to appropriate services.

Published: Mar 30, 2026